Tag: Dinutuximab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Dinutuximab

FDA Approves Y-mAbs' DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma

Added to Collection on: 2020-11-25 21:56:15

Tags for this article:

Drugs
Clinical medicine
Cancer treatments
Orphan drugs
Breakthrough therapy
Brain tumor
Neuroblastoma
Monoclonal antibodies
Antineoplastic drugs
Dinutuximab
Targeted molecular therapy for neuroblastoma
Y-mAbs Therapeutics Inc.
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Risk Adjusted Net Present Value: What is the current valuation of United Therapeutics's Ralinepag

Added to Collection on: 2024-12-13 19:45:16

Tags for this article:

Valuation
Fundamental analysis
Risk-adjusted net present value
Capital budgeting
United Therapeutics
Net present value
GlobalData
Pulmonary hypertension
Dinutuximab
Pharmaceutical industry
Tadalafil

Click the tags to see associated articles and topics

View Article Details
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high ... - Nature

Added to Collection on: 2025-02-14 18:40:43

Tags for this article:

Brain tumor
Neuroblastoma
Dinutuximab
Orphan drugs
Naxitamab
GD2
Targeted molecular therapy for neuroblastoma
GM-CSF

Click the tags to see associated articles and topics

View Article Details
Y-mAbs announces publication of Phase 2 interim results on naxitamab | Markets Insider

Added to Collection on: 2025-03-03 14:04:39

Tags for this article:

Brain tumor
Neuroblastoma
Naxitamab
Clinical endpoint
Dinutuximab
y-mabs therapeutics

Click the tags to see associated articles and topics

View Article Details
Y-mAbs Announces Publication of Phase 2 Interim Results in Nature Communications

Added to Collection on: 2025-03-03 12:32:41

Tags for this article:

Brain tumor
Neuroblastoma
Naxitamab
GD2
Radioimmunotherapy
Dinutuximab
Y-mAbs Therapeutics Inc.
GM-CSF

Click the tags to see associated articles and topics

View Article Details
Book a Demo